Iovance Biotherapeutics, Inc. Alternatives & Competitors
12 companies similar to Iovance Biotherapeutics, Inc. — Iovance is a patient-centric, collaborative organization that is driven to chang...
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
Houston, United States
Allogene Therapeutics
A biotechnology company catalyzing cancer treatment through the development of CAR T thera...
South San Francisco, Unit...
PhotonPharma
An immuno-oncology company unleashing the body to fight cancer
Fort Collins, United Stat...
Blueprint Medicines
Striving to improve and extend patients' lives
Cambridge, United States
Track all Iovance Biotherapeutics, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Immune-Onc Therapeutics
Science at Our Core. Patients in Our Hearts.
Palo Alto, United States
Focal Medical, Inc. (acquired by Continuity Biosciences)
We are developing novel targeted therapeutic products based on our innovative local drug-d...
Cary, United States
Mustang Bio
A fortress biotech Company
Waltham, United States
Guardian Bio
Reinventing dendritic cell therapy for solid tumors
Sana Biotechnology, Inc.
Focused on creating and delivering engineered cells as medicines for patients
Seattle, United States
Bicycle Therapeutics
Precision-Guided Therapeutics
Cambridge, United Kingdom
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
Hyfe
AI-powered cough-tracking & insights. Precision medicine for respiratory health
Wilmington, United States
About Iovance Biotherapeutics, Inc.
Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.
TIL Therapy Development, Clinical Research, Manufacturing at Cell Therapy Center, Scientific Publications & Presentations, Pipeline Development for Advanced Solid Tumor Cancers
Patients with Advanced Solid Tumor Cancers, Healthcare Providers, Clinical Researchers, Pharmaceutical Investors
Patient-Centric Organization, Cancer Treatment Innovation, Tumor Infiltrating Lymphocytes (TIL) Therapy, Autologous T-Cell Treatment, Immunotherapy Development, Solid Tumor Focus, Gene-Edited Cell Therapy, Cell Therapy Manufacturing, Clinical Data Development, Regulatory Approval Preparation, San Francisco Bay Area Headquarters, Philadelphia Manufacturing Facility, Tampa Research Site, Commercial Launch Execution, Cancer Immunotherapy Commercialization
B2B, B2D
Product Sales, Service Fee, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Iovance Biotherapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Iovance Biotherapeutics, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 13 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
